Funders › CA › Torrey Coast Foundation › 2022
Grants paid by Torrey Coast Foundation, tax year 2022
EIN 85-4224393 · San Diego, CA · Form 990-PF, Part XV · NTEE T22
In tax year 2022, Torrey Coast Foundation (EIN 85-4224393) reported 15 grants paid totaling $6,638,495. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2022
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2022 | The Entertainment Industry Foundation Los Angeles, CA | B | $4,500,000 | approved, future | DONATION TO SU2C/EIF TO FUND CERTAIN CANCER RESEARCH PROJECTS. | 202333189349103463 |
| 2022 | Columbia University New York, NY | C | $2,000,000 | approved, future | TO ESTABLISH THE TORREY COAST STRATEGIC RESEARCH FUND. THE RESEARCH FUND SHALL BE USED TO SUPPORT GASTRIC AND ESOPHAGEAL CANCER RESEARCH. | 202333189349103463 |
| 2022 | The Entertainment Industry Foundation Los Angeles, CA | B | $1,500,000 | paid | DONATION TO SU2C/EIF TO FUND CERTAIN CANCER RESEARCH PROJECTS. | 202333189349103463 |
| 2022 | Uc San Diego Foundation La Jolla, CA | U | $1,285,000 | paid | INSTITUTE FOR NETWORK MEDICINE FOR A STUDY ENTITLED "RAPID TRANSLATION OF NOVEL IMMUNE CELL-TARGETED THERAPEUTICS IN ESOPHAGEAL AND GASTROESOPHAGEAL CANCERS", INSTITUTE FOR NETWORK MEDICINE FOR RESEARCH OF THE AREA OF GASTRIC CANCER, AND MOORES CANCER CENTER IMMUNOTHERAPY INNOVATION FUND. | 202333189349103463 |
| 2022 | Columbia University New York, NY | C | $1,017,800 | paid | FOR CENTRALIZING GASTROESOPHAGEAL CANCER RESOURCES GIFT FUND, GRANT PROPOSAL" GENERATING GASTROESOPHAGEAL TUMOR TISSUE MICROARRAYTS", TO ESTABLISH THE TORREY COAST STRATEGIC RESEARCH FUND, WHICH SHALL BE USED TO SUPPORT GASTRIC AND ESOPHAGEAL CANCER RESEARCH, TO CONDUCT THE SCIENCE DESCRIBED IN DR. WANG AND BASS'S PROPOSAL,"TARGETING MYELOID CELLS TO ENHANCE IMMUNOTHERAPY TARGETING T CELLS", AND FOR GRANT PROPOSAL" GENERATING GASTROESOPHAGEAL TUMOR TISSUE MICROARRAYTS". | 202333189349103463 |
| 2022 | Cornell University - the Joan and Sanford I Weill Medical College New York, NY | U | $574,998 | paid | TO PROMOTE AND ENHANCE THE WORK OF THE MEDICAL COLLEGE THROUGH THE SUPPORT OF RESEARCH TO GENERATE INFORMATION ON THE MECHANISMS OF "DIFFUSE" MESENCHYMAL TYPE OF GASTRIC CANCER AND TO PROMOTE AND ENHANCE THE WORK OF THE MEDICAL COLLEGE THROUGH THE SUPPORT OF RESEARCH IN IDENTIFYING AND TESTING EVIDENCE-BASED TARGETED THERAPEUTIC STRATEGIES IN GASTRIC CANCER: TARGETING TGF AND THE IMMUNE MICROENVIRONMENT. | 202333189349103463 |
| 2022 | The Broad Institute Inc Pasadena, CA | U | $513,181 | paid | FOR THE PROJECT, ADAPTING 3D CANCER ORGANOIDS INTO MONOLAYER CELL LINES TO EXPAND MODEL UTILIZATION AND FOR SCREENING COMPOUNDS USING THE PRISM SCREENING PLATFORM. | 202333189349103463 |
| 2022 | Memorial Sloan-Kettering Cancer Center New York, NY | U | $396,426 | paid | TO ORGANIZE RESEARCH IN ESOPHAGOGASTRIC CANCER UNDER THE DIRECTION OF DRS. YELENA JANJIGIAN AND KARUNA GANESH. | 202333189349103463 |
| 2022 | The Degregorio Family Foundation New York, NY | C | $375,000 | paid | TO SUPPORT THE COLLABORATIVE RSERACH GRANTS FUNDED FOR GASTRIC AND ESOPHAGEAL CANCER RESEARCH, | 202333189349103463 |
| 2022 | Insititue of Molecular Cell Biology Immunos | U | $247,000 | paid | FOR GRANT PROPOSAL "EVALUATING GASTRIC CANCER THERAPEUTICS IN OUR CLDN18-ATK GENETICALLY ENGINEERED MOUSE MODEL OF GASTRIC CANCER". | 202333189349103463 |
| 2022 | Cornell University - the Joan and Sanford I Weill Medical College New York, NY | U | $200,000 | approved, future | TO PROMOTE AND ENHANCE THE WORK OF THE MEDICAL COLLEGE THROUGH THE SUPPORT OF RESEARCH TITLED "ABROGATION OF NEUTROPHIL MEDIATED PRO-TUMORIGENIC INTERACTIONS WITH ESOPHAGEAL AND GASTRIC ADENOCARCINOMAS." | 202333189349103463 |
| 2022 | University of Texas Md Anderson Cancer Center Houston, TX | U | $200,000 | paid | "PERSONALIZED THERAPY FOR PATIENTS WITH ARID1A DEFICIT GASTRIC ADENOCARCINOMA (GAC)". | 202333189349103463 |
| 2022 | University of Utah Salt Lake City, UT | B | $150,000 | paid | TO DEVELOP AND TEST NOVEL THERAPEUTICS FOR GASTRIC CANCER | 202333189349103463 |
| 2022 | Columbia University New York, NY | C | $150,000 | approved, future | "CENTRALIZING GASTROESOPHAGEAL CANCER RESOURCES GIFT FUND". | 202333189349103463 |
| 2022 | Broad Institute Pasadena, CA | U | $127,644 | approved, future | FOR THE PROJECT, ADAPTING 3D CANCER ORGANOIDS INTO MONOLAYER CELL LINES TO EXPAND MODEL UTILIZATION. | 202333189349103463 |
| 2022 | Massachusettes General Hospital Boston, MA | U | $101,200 | paid | TO SUPPORT RSEARCH INCLUDING, BUT NOT LIMITED TO, EX-VIVO SENSITIVITY TESTING, BIOSENSOR EFFORTS, AND IDENTIFICATION OF DRUG AGENTS TO GENERATE CLINICAL TRIAL PILOT DATA IN REGARDS TO THE TREATMENTS OF ESOPHAGOGASTRIC CANCER | 202333189349103463 |
| 2022 | Hias Inc Silver Spring, MD | B | $100,000 | paid | TO SUPPORT UKRANIAN REFUGEES SEEKING SAFETY IN JEWISH COMMUNITIES IN EUROPE. | 202333189349103463 |
| 2022 | Emory University School of Medicine Atlanta, GA | U | $76,890 | paid | FOR GRANT PROPOSAL" ADENOSQUAMOUS CARCINOMAS OF THE ESOPHAGUS: UNIQUE BIOLOGICAL AND THERAPEUTIC INSIGHTS FROM A RARE CANCER". | 202333189349103463 |
| 2022 | Cornell University - the Joan and Sanford I Weill Medical College New York, NY | U | $62,400 | approved, future | TO PROMOTE AND ENHANCE THE WORK OF THE MEDICAL COLLEGE THROUGH THE SUPPORT OF RESEARCH IN IDENTIFYING AND TESTING EVIDENCE-BASED TARGETED THERAPEUTIC STRATEGIES IN GASTRIC CANCER: TARGETING TGF AND THE IMMUNE MICROENVIRONMENT. | 202333189349103463 |
| 2022 | University of Pennsylvania School of Medicine Philadelphia, PA | U | $55,000 | approved, future | FOR GRANT PROPOSAL "SYSTEMATIC IDENTIFICATION AND PRIORITIZATION OF IMMUNOTHERAPY TARGETS FOR TREATMENT OF GASTROESOPHAGEAL MALIGNANCIES." | 202333189349103463 |
| 2022 | University of Pennsylvania School of Medicine Philadelphia, PA | U | $55,000 | paid | FOR GRANT PROPOSAL "SYSTEMATIC IDENTIFICATION AND PRIORITIZATION OF IMMUNOTHERAPY TARGETS FOR TREATMENT OF GASTROESOPHAGEAL MALIGNANCIES". | 202333189349103463 |
| 2022 | Case Western Reserve University Cleveland, OH | U | $46,000 | paid | COLLABORATION WITH THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER AND COLUMBIA UNIVERSITY'S GI ONCOLOGY TEAMS. | 202333189349103463 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.